ArticleVaccines2022

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies.

Osman O Radhwi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.